Observational Study of Postoperative Treatment in the Cases of Complete Excision for Non-Small-Cell Lung Cancer of Pathological Stage I (T1>2 cm, TNM Classification Version 6)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015732

Enrollment

5000

Registered

2014-11-21

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Among the patients with non-small-cell lung cancer which has been completely excised by surgical lung lobectomy or more extensive surgical resection and lymph node dissection/selective lymph node dissection of at least ND2a, and has been diagnosed as Pathological Stage I (T1>2 cm, TNM classification, Version 6) during the period from the starting month at each site, as defined elsewhere, to December 31, 2013, those who have not been enrolled in the clinical study of postoperative treatment will be selected as the subjects.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
Study A Reasons why the subjects have not been enrolled in the clinical study and the percentages Study B Overall survival	—

Secondary

Measure	Time frame
Study A ?Patient backgrounds ?Treatment implementation rate, contents of treatment, adherence ?Overall survival time ?Disease specific survival ?Correlations among above endpoints Study B ?Disease specific survival ?Patient backgrounds ?Treatment implementation rate, adherence ?Correlations among above endpoints	—

Countries

Japan

Outcome results